Inactive Instrument
Abliva AB Stock
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded
| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 2014-01-09 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 2023-01-31 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 2017-11-05 | |
| Director/Board Member | 66 | 2017-04-26 | |
David Bejker
BRD | Director/Board Member | 51 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-03-06 | Sell | Founder | 574,978 | 0.0357% | ||
| 25-03-06 | Sell | Founder | 574,978 | 0.0357% | ||
| 25-02-11 | Sell | Chairman | 1,000,000 | 0.0620% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 76M | |
| -0.50% | -0.08% | +56.78% | +107.62% | 54.92B | |
| -0.34% | +3.51% | +45.55% | +40.16% | 44.31B | |
| -0.97% | +4.18% | -15.24% | -19.93% | 22.96B | |
| -3.22% | -4.42% | -6.82% | +373.30% | 21.12B | |
| -2.91% | -1.18% | +7.21% | -36.53% | 16.31B | |
| -2.54% | -3.51% | +5.39% | -41.95% | 15.19B | |
| -0.66% | -0.58% | +26.19% | +175.98% | 13.32B | |
| +1.48% | +11.36% | +22.59% | - | 12.48B | |
| +0.32% | +2.81% | +96.37% | +213.49% | 11.21B | |
| Average | -0.93% | +2.75% | +26.45% | +101.52% | 23.54B | |
| Weighted average by Cap. | -0.99% | +2.86% | +30.94% | +93.42% |
Employees
6
